These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9988270)

  • 1. Activating SRC mutation in a subset of advanced human colon cancers.
    Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
    Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.
    Irby R; Mao W; Coppola D; Jove R; Gamero A; Cuthbertson D; Fujita DJ; Yeatman TJ
    Cell Growth Differ; 1997 Dec; 8(12):1287-95. PubMed ID: 9419417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRC gene expression in human cancer: the role of transcriptional activation.
    Dehm SM; Bonham K
    Biochem Cell Biol; 2004 Apr; 82(2):263-74. PubMed ID: 15060621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients.
    Laghi L; Bianchi P; Orbetegli O; Gennari L; Roncalli M; Malesci A
    Br J Cancer; 2001 Jan; 84(2):196-8. PubMed ID: 11161376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
    Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
    Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
    Staley CA; Parikh NU; Gallick GE
    Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical amino acid substitutions in the Src SH3 domain that convert c-Src to be oncogenic.
    Miyazaki K; Senga T; Matsuda S; Tanaka M; Machida K; Takenouchi Y; Nimura Y; Hamaguchi M
    Biochem Biophys Res Commun; 1999 Oct; 263(3):759-64. PubMed ID: 10512753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Src transformation fingerprint in human colon cancer.
    Malek RL; Irby RB; Guo QM; Lee K; Wong S; He M; Tsai J; Frank B; Liu ET; Quackenbush J; Jove R; Yeatman TJ; Lee NH
    Oncogene; 2002 Oct; 21(47):7256-65. PubMed ID: 12370817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The road to Src.
    Martin GS
    Oncogene; 2004 Oct; 23(48):7910-7. PubMed ID: 15489909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alternative SRC promoter usage in HepG2 hepatocellular carcinoma cells.
    Dehm SM; Bonham K
    Gene; 2004 Aug; 337():141-50. PubMed ID: 15276210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
    Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
    Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of the p56lck by colon tumors: a marker of their invasive capacity?].
    Rouer E
    Bull Cancer; 2004 Dec; 91(12):928-40. PubMed ID: 15634634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
    Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
    Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel germ line juxtamembrane Met mutation in human gastric cancer.
    Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
    Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.